Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/178974
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gómez Valenzuela, Fernán | - |
dc.contributor.author | Escobar, Enrico | - |
dc.contributor.author | Pérez Tomás, Ricardo | - |
dc.contributor.author | Montecinos, Viviana P. | - |
dc.date.accessioned | 2021-07-12T09:54:48Z | - |
dc.date.available | 2021-07-12T09:54:48Z | - |
dc.date.issued | 2021-06-10 | - |
dc.identifier.uri | https://hdl.handle.net/2445/178974 | - |
dc.description.abstract | Microbial infections are a major public health concern. Antimicrobial peptides (AMPs) have been demonstrated to be a plausible alternative to the current arsenal of drugs that has become inefficient due to multidrug resistance. Herein we describe a new AMP family, namely the super-cationic peptide dendrimers (SCPDs). Although all members of the series exert some antibacterial activity, we propose that special attention should be given to (KLK)2KLLKLL-NH2 (G1KLK-L2KL2), which shows selectivity for Gram-negative bacteria and virtually no cytotoxicity in HepG2 and HEK293. These results reinforce the validity of the SCPD family as a valuable class of AMP and support G1KLK-L2KL2 as a strong lead candidate for the future development of an antibacterial agent against Gram-negative bacteria. | - |
dc.format.extent | 16 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Frontiers Media SA | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3389/fonc.2021.686792 | - |
dc.relation.ispartof | Frontiers in Oncology, 2021, vol. 11, num. 686792 | - |
dc.relation.uri | https://doi.org/10.3389/fonc.2021.686792 | - |
dc.rights | cc by (c) Gómez Valenzuela, Fernán et al., 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Càncer | - |
dc.subject.classification | Inflamació | - |
dc.subject.classification | Fenotip | - |
dc.subject.other | Cancer | - |
dc.subject.other | Inflammation | - |
dc.subject.other | Phenotype | - |
dc.title | The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition | - |
dc.type | info:eu-repo/semantics/article | - |
dc.date.updated | 2021-07-09T08:27:28Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 34178680 | - |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
fonc-11-686792.pdf | 1.93 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License